InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Clements Ian, Chief Financial Officer. Director active across 1 companies, notably Mirum Pharmaceuticals, Inc.. In total, 11 disclosures have been published. Total volume traded: €18k. The latest transaction was filed on 10 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations11 total
€14,4901,125 shares@ €12.87960.0004% mcap21.7% of flow
Common Stock
SEC:0001209191-22-028719:0·
010,000 shares0
Common Stock
SEC:0001209191-22-002426·
010,000 shares0
Common Stock
SEC:0001209191-22-002426:0·
€8,964700 shares@ €12.80580.0002% mcap34.3% of flow
Common Stock
SEC:0001209191-21-067068·
Ideal exit: 21 Aug 2022 (T+270)
€8,964700 shares@ €12.80580.0002% mcap13.4% of flow
Common Stock
SEC:0001209191-21-067068:0·
Ideal exit: 21 Aug 2022 (T+270)
€5,338458 shares@ €11.65530.0001% mcap20.4% of flow
Common Stock
SEC:0001209191-21-064447·
€5,338458 shares@ €11.65530.0001% mcap8.0% of flow
Common Stock
SEC:0001209191-21-064447:0·
09,375 shares0
Common Stock
SEC:0001209191-21-058607·
09,375 shares0
Common Stock
SEC:0001209191-21-058607:0·
€11,813981 shares@ €12.04190.0003% mcap45.2% of flow
Common Stock
SEC:0001209191-21-032139·
€11,813981 shares@ €12.04190.0003% mcap17.7% of flow
Common Stock
SEC:0001209191-21-032139:0·
11 of 11 declarations
About Clements Ian
Ian Clements is the Chief Financial Officer at Mirum Pharmaceuticals, Inc. He is responsible for the financial management of the company, including financial planning and risk management. His role is essential in ensuring the growth and financial stability of Mirum.
